EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
07.05.26
/
50%
€11.30
Target price
07.05.27
€31.47
Performance (%)
-5.31%
Price
08:55
?
Summary
This prediction is currently active. With a performance of -5.31%, the BUY prediction for EyePoint Pharmaceuticals Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 07.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | -5.769% | -5.769% |
| iShares Core DAX® | -2,80 % | -1,40 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % |
| iShares S&P 500 | -3,41 % | 0,40 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its price target lowered by Royal Bank Of Canada from $39.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.59
06.11.25
06.11.25
€33.89
06.11.26
06.11.26
11.55%
08:55
08:55
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.18
17.06.25
17.06.25
€24.24
17.06.26
17.06.26
30.84%
08:55
08:55